Plasticell

Proteomics firm Cellzome said this week it has won more than €2.3 million ($3.1 million) in grants funding its participation in three separate research projects.

Plasticell has developed "serum-free protocols that direct the differentiation of Stemnion's stem cells into hard-to-obtain lineages."

Plasticell has formed a spinout called Progenitor Labs, which will focus on regenerative drug discovery.

The British stem cell research tools firm plans to use the funds to expand its business development and marketing activities.

The collaboration involves using Sigma-Aldrich's CompoZr zinc finger nuclease technology and Plasticell's CombiCult high-throughput screening system.

Hundreds of scientists have signed a letter criticizing the open-access Plan S, ScienceInsider reports.

NPR speaks with Rep. Eddie Bernice Johnson (D-Texas) about the US House of Representatives science committee.

A start-up company aiming to match cancer patients to treatments closes after about six weeks, Stat News reports.

In PLOS this week: somatic mutation associations unearthed in thousands of cancer exomes, pathogen detection assay, and more.